Global Dried Blood Spot Collection Cards Market Size By Type (Whatman 903, Ahlstrom 226), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Dried Blood Spot (DBS) Collection Cards Market was valued at USD 420 million in 2023 and is projected to surpass USD 780 million by 2031, growing at a CAGR of 7.8% during the forecast period (2023-2031).

The demand for dried blood spot collection cards is increasing due to their advantages in diagnostic applications, forensic testing, newborn screening, and research. DBS collection cards allow for easy sample collection, transport, and storage, making them a valuable tool in resource-limited settings and decentralized healthcare systems. The expansion of personalized medicine, increased global screening programs, and advancements in laboratory technologies are fueling the growth of the market.

Market Drivers

1. Rising Demand for Decentralized Diagnostic Testing

With an increasing emphasis on decentralized and remote diagnostic testing, DBS collection cards are gaining traction in clinical diagnostics, infectious disease screening, and therapeutic drug monitoring.

2. Growth in Neonatal and Metabolic Disorder Screening Programs

Governments and healthcare organizations are expanding newborn screening programs to detect metabolic and genetic disorders early, significantly boosting demand for dried blood spot collection cards.

3. Advantages Over Traditional Blood Collection Methods

DBS collection cards eliminate the need for venipuncture, require minimal blood volume, and allow long-term storage without refrigeration, making them ideal for remote and resource-limited healthcare settings.

Market Restraints

1. Variability in Sample Quality

Inconsistencies in blood sample collection, drying time, and storage conditions can impact test accuracy, posing a challenge for adoption in critical diagnostic applications.

2. Regulatory and Standardization Issues

The lack of uniform regulatory guidelines for DBS sample handling, storage, and analysis creates complexities in laboratory testing and clinical adoption.

Market Opportunities

1. Expansion of Telemedicine and At-Home Testing

The rise in telemedicine and at-home diagnostic testing presents significant growth opportunities for DBS collection cards in remote sample collection for genetic, infectious disease, and chronic disease monitoring.

2. Increased Adoption in Forensic and Toxicology Applications

DBS collection is being increasingly utilized in forensic toxicology, doping tests, and law enforcement applications due to its stability and ease of transportation.

Market by Application Insights

Newborn Screening: The largest segment in 2023, driven by government mandates and increased awareness.

Infectious Disease Testing: Growing due to the rising prevalence of HIV, hepatitis, and other infectious diseases.

Forensic and Drug Testing: Expanding due to regulatory compliance and advancements in analytical techniques.

Market by End-Use Insights

Hospitals & Diagnostic Labs: Dominating the market due to widespread use in newborn screening and disease diagnostics.

Research & Academia: Growing adoption in epidemiological studies and biomarker discovery.

Forensic Laboratories: Increasingly using DBS cards for toxicology and law enforcement applications.

Market by Regional Insights

North America holds the largest share, driven by strong newborn screening initiatives and a well-established diagnostic infrastructure.

Europe follows closely, with increasing adoption in forensic testing and chronic disease screening.

Asia-Pacific is expected to witness the highest growth, fueled by expanding healthcare access, growing disease burden, and government-supported screening programs.

Competitive Scenario

Key players operating in the Global Dried Blood Spot Collection Cards Market include:

PerkinElmer, Inc.

GE Healthcare

QIAGEN N.V.

F. Hoffmann-La Roche Ltd.

Ahlstrom-Munksjö

Shimadzu Corporation

Whatman (Cytiva)

Spot On Sciences, Inc.

These companies focus on research and development, product innovations, and strategic partnerships to expand their market presence.

Scope of Work – Global Dried Blood Spot Collection Cards Market

Report Metric Details

Market Size (2023) USD 420 million

Projected Market Size (2031) USD 780 million

CAGR (2023-2031) 7.8%

Key Segments Application (Newborn Screening, Infectious Disease Testing, Forensic & Drug Testing), End-Use (Hospitals & Labs, Research, Forensics)

Key Market Drivers Rising Demand for Decentralized Testing, Growth in Neonatal Screening, Advantages Over Traditional Methods

Opportunities Expansion in Telemedicine, Forensic Applications Growth

Key Market Developments

2023: PerkinElmer expanded its newborn screening product portfolio with advanced DBS collection card solutions.

2023: GE Healthcare launched a next-generation DBS collection card with enhanced sample stability for infectious disease diagnostics.

2024: QIAGEN announced a collaboration with leading research institutes to enhance DBS-based biomarker discovery.

2025: Spot On Sciences, Inc. introduced a self-collection DBS kit for at-home diagnostic applications.

FAQs

1. What is the current market size of the Global Dried Blood Spot Collection Cards Market?

The market was valued at USD 420 million in 2023.

2. What is the major growth driver of the Global Dried Blood Spot Collection Cards Market?

The key growth driver is the rising demand for decentralized diagnostic testing and expansion of newborn screening programs.

3. Which is the largest region during the forecast period in the Global Dried Blood Spot Collection Cards Market?

North America holds the largest market share, driven by strong healthcare infrastructure and newborn screening initiatives.

4. Which segment accounted for the largest market share in the Global Dried Blood Spot Collection Cards Market?

The Newborn Screening segment dominated the market in 2023 due to government-led screening programs.

5. Who are the key market players in the Global Dried Blood Spot Collection Cards Market?

Major players include PerkinElmer, GE Healthcare, QIAGEN, Roche, Ahlstrom-Munksjö, and Whatman (Cytiva).

This report provides an in-depth analysis of the Global Dried Blood Spot Collection Cards Market, ensuring comprehensive, SEO-friendly, and data-driven insights aligned with the latest market trends.